Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03419650 · ClinicalTrials.gov registry record · Phase 4
Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)
A Phase 4 study, sponsored by IRIS Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03419650: Completed Phase 4 study, sponsored by IRIS Research and Development.
NCT03419650 is a Phase 4 study that has completed, run by IRIS Research and Development. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03419650, a Phase 4 study, has completed, sponsored by IRIS Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
Demonstrate the clinical value of Acthar TM in patients with active Psoriatic Arthritis who lack adequate response to DMARDS, and the quantification of response by clinical, serologic and structural parameters.
Primary Outcome
1\. To demonstrate the efficacy of Acthar for the treatment of patients with active psoriatic arthritis and who have not had an adequate response to non-biological DMARDs based on the proportion of subjects achieving a 20% improvement in the number of tender and number of swollen joints, and a 20% improvement in three of the following five criteria: patient global assessment, physician global assessment, Health Assessment Questionnaire (HAQ), visual analog pain scale, and erythrocyte sedimentati
Interventions
- DRUG ACTHar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2021-08-25 |
| Phase | Phase 4 |
What the finished NCT03419650 record still lists
NCT03419650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which ACTHar is the first listed.
NCT03419650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03419650 about?
NCT03419650 is a clinical study titled "Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)". Demonstrate the clinical value of Acthar TM in patients with active Psoriatic Arthritis who lack adequate response to DMARDS, and the quantification of response by clinical, serologic and structural parameters.
What is the current status of trial NCT03419650?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2018-07-20. Estimated completion is 2021-08-25.
What interventions are being tested in trial NCT03419650?
The interventions under investigation include: ACTHar (DRUG).
Who is sponsoring clinical trial NCT03419650?
This trial is sponsored by IRIS Research and Development, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03419650's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI